Direct-to-consumer sales of medications often mean lower prices and more convenience for patients.

One of the biggest gripes around weight loss medications like Wegovy and Zepbound is the high price tag. At $1,000 or more a ...

The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage ...

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

Denmark-based Novo Nordisk, which makes Ozempic, Rybelsus and Wegovy; and Indianapolis-based Eli Lilly, which makes Zepbound, ...

The White House announced reduced pricing for the popular weight-loss drugs made by Eli Lilly and Novo Nordisk.

The Trump administration’s pact with drugmakers to lower the price of GLP-1 drugs could pave the way for millions more to ...

Trump's deal slashes GLP-1 drug costs for Medicare beneficiaries and others, unlocking coverage for millions with obesity and ...

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.

Trump said his administration reached an agreement with Novo Nordisk and Eli Lilly to lower the cost of GLP-1 weight loss ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.